Job title: Vice President – Clinical Development
Dr. Walker is a medical oncologist who received his medical degree from the University of Oklahoma, followed by training in internal medicine, hematology/oncology, and hematopoietic stem cell transplant at Oregon Health Sciences University. After practicing for several years in Seattle as a hematologist/oncologist, including directing a multidisciplinary Thoracic Oncology Clinic and Anticoagulation Clinic, he has been working in drug development since 2011, including stints at Oncothyreon, Cascadian Therapeutics, and now Seattle Genetics. He has been involved in the clinical development of tucatinib since 2013, and now serves as the Global Development lead for TUKYSA and Vice President of Clinical Development at Seattle Genetics.
Live Presenter Q&A 10:20 am
day: Day Two
The Use of Highly Selective TKIs for HER2+ CNS Metastases- Tucatinib in Combination With Capecitabine & Trastuzumab 9:20 am
• Expanding clinical trials to include patients with active brain metastases • Exploration of the use of dual HER2 inhibition • Understanding the complexity of clinical endpoints for measuring activity of therapeutics against brain metastasesRead more
day: Day Two